Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC in Relapse Ovarian Cancer (CHIPOR)
NCT01376752Phase 3Active, not recruiting
- Sponsor
- Unicancer
- Start
- Apr 2011
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of cisplatin in ovarian cancer, sponsored by Unicancer. Started Apr 2011; status: active, not recruiting.
02
Drugs
cisplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01376752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376752.